Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation
Authors
Keywords
-
Journal
Progress in Transplantation
Volume 26, Issue 4, Pages 348-355
Publisher
SAGE Publications
Online
2016-08-24
DOI
10.1177/1526924816664083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis
- (2015) Andrea Mancuso et al. DIGESTIVE AND LIVER DISEASE
- Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review
- (2015) Nicola de’Angelis WORLD JOURNAL OF GASTROENTEROLOGY
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States
- (2014) Sean F Altekruse et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series
- (2014) G. Sapisochin et al. ANNALS OF SURGICAL ONCOLOGY
- Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation
- (2014) Giovanni Perricone et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation
- (2014) P. De Simone et al. TRANSPLANTATION PROCEEDINGS
- Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation
- (2013) Abhijeet Waghray et al. CLINICAL TRANSPLANTATION
- Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study
- (2013) Carlo Sposito et al. JOURNAL OF HEPATOLOGY
- Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma
- (2013) Manuel Rodríguez-Perálvarez et al. JOURNAL OF HEPATOLOGY
- Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends
- (2013) Matthias S. Matter et al. JOURNAL OF HEPATOLOGY
- Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue
- (2013) Andrea Mancuso et al. JOURNAL OF HEPATOLOGY
- Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
- (2012) Arndt Weinmann et al. DIGESTIVE AND LIVER DISEASE
- Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation
- (2012) Claudio Zavaglia et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
- (2012) Christophe Duvoux et al. GASTROENTEROLOGY
- Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
- (2012) Christian Toso et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge
- (2012) Martin-Walter Welker et al. TRANSPLANT INTERNATIONAL
- Sorafenib Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation
- (2012) G.C. Sotiropoulos et al. TRANSPLANTATION PROCEEDINGS
- Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantation?
- (2012) A. Vitale et al. TRANSPLANTATION PROCEEDINGS
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Multidisciplinary Management of Recurrent Hepatocellular Carcinoma Following Liver Transplantation
- (2011) Peter J. Kneuertz et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
- (2011) Pierre-Alain Clavien et al. LANCET ONCOLOGY
- Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
- (2011) Wenhua Liang et al. LIVER TRANSPLANTATION
- Treatment of recurrent hepatocellular carcinoma after liver transplantation
- (2011) Eric Davis et al. LIVER TRANSPLANTATION
- Using Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation—Interactions Between Calcineurin Inhibitor: Two Case Reports
- (2011) T. Takahara et al. TRANSPLANTATION PROCEEDINGS
- Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
- (2010) D. H. Yoon et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma
- (2009) Christian Toso et al. HEPATOLOGY
- Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Allocation System and Predictors of Survival
- (2008) George N. Ioannou et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search